Changes

20 bytes added ,  01:35, January 8, 2008
Provide actual article citation, and correct mistyped statistic. The original author probably intended to put 30%, not 3%. The actual number is 26.8% as shown by the reference.
Line 12: Line 12:  
The long-term consequences of the HPV vaccine are unknown as there have not been any long-term studies.  Children in the 9-year-old age group have been monitored for 18 months, and there have been no studies of possible longer-term risks of the vaccine.  Between July 2006 and January 2007, there were 82 reports of adverse events filed with the Vaccine Adverse Event Reporting System ([[VAERS]]) following the receipt of the vaccine.
 
The long-term consequences of the HPV vaccine are unknown as there have not been any long-term studies.  Children in the 9-year-old age group have been monitored for 18 months, and there have been no studies of possible longer-term risks of the vaccine.  Between July 2006 and January 2007, there were 82 reports of adverse events filed with the Vaccine Adverse Event Reporting System ([[VAERS]]) following the receipt of the vaccine.
   −
A study published February 28, 2007 in the Journal of the American Medical Association (JAMA) <ref>JAMA 297(8):813-819, February 28, 2007</ref> disclosed that about 3% of women are infected in their lifetime by the particular types of HPV (Types 6, 11, 16, 18) targeted by the vaccine. <!-- ''this assertion is dubious; the latest figures from CDC [http://www.cdc.gov/std/stats/trends2006.htm here] say that chlamydia is the most common; Time may be applying different critera, which should be stated.''  ''Time'' magazine calls HPV "the most common sexually transmitted infection".<ref>[http://www.time.com/time/nation/article/0,8599,1206813,00.html  Defusing the War Over the "Promiscuity" Vaccine]</ref>-->
+
A study published February 28, 2007 in the Journal of the American Medical Association (JAMA) <ref>http://jama.ama-assn.org/cgi/content/abstract/297/8/813</ref> disclosed that about 26.8% of women are infected in their lifetime by the particular types of HPV (Types 6, 11, 16, 18) targeted by the vaccine. <!-- ''this assertion is dubious; the latest figures from CDC [http://www.cdc.gov/std/stats/trends2006.htm here] say that chlamydia is the most common; Time may be applying different critera, which should be stated.''  ''Time'' magazine calls HPV "the most common sexually transmitted infection".<ref>[http://www.time.com/time/nation/article/0,8599,1206813,00.html  Defusing the War Over the "Promiscuity" Vaccine]</ref>-->
 
Merck manufactures the HPV vaccine ("Gardasil") and sells it for $360 ($120 per shot in a three-shot series).  Its package insert explains the limitations of the vaccine and describes its testing for safety and efficacy.<ref>http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdf</ref>
 
Merck manufactures the HPV vaccine ("Gardasil") and sells it for $360 ($120 per shot in a three-shot series).  Its package insert explains the limitations of the vaccine and describes its testing for safety and efficacy.<ref>http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdf</ref>
  
nsTeam1RO, nsTeam1RW, nsTeam1_talkRO, nsTeam1_talkRW
675

edits